Spyre Therapeutics to Participate in Upcoming March Investor Conferences
Press Releases
Spyre Therapeutics, Inc.  
February 25, 2025

Spyre Therapeutics to Participate in Upcoming March Investor Conferences

WALTHAM, Mass., Feb. 25, 2025 /PRNewswire/ -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company advancing best-in-class antibody engineering, dose optimization, and rational therapeutic combinations for the treatment of

avatar profile Olean Times Herald

Olean Times Herald


Local & Social